Concepedia
4
Publications
86
Citations
H-Index
2019
Active since
Affiliations
Medicines Evaluation Board(Current)
Erasmus MC
University of Groningen
Netherlands Pharmacovigilance Centre Lareb
Nafise Ghalandari is an author at Medicines Evaluation Board.
Publications per year
2019–2022
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
Nafise Ghalandari, Erik Kemper, Ineke Crijns et al. · Annals of the Rheumatic Diseases · 2021 · 27 citations · Full text
Reported congenital malformations after exposure to non‐tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance
Nafise Ghalandari, H. J. M. J. Crijns, Jorieke E. H. Bergman et al. · British Journal of Clinical Pharmacology · 2022 · 22 citations · Full text
The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
Nafise Ghalandari, Radboud J. E. M. Dolhain, Johanna M W Hazes et al. · British Journal of Clinical Pharmacology · 2019 · 21 citations · Full text
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance
Nafise Ghalandari, H. J. M. J. Crijns, Radboud J. E. M. Dolhain et al. · Lupus · 2022 · 16 citations · Full text
Rows per page
1–4 of 4